Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter H Koch

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Reviews. Drug Discovery|September 2, 2004
Technology platforms for pharmacogenomic diagnostic assaysWalter H Koch
New Biotechnology|March 7, 2012
Co-development of a companion diagnostic for targeted cancer therapySuzanne Cheng, Walter H Koch, Lin Wu
Biotechniques|October 21, 2005
Clinical applications of microarray-based diagnostic testsLin Wu, P Mickey Williams, Walter H Koch
Methods in Molecular Medicine|June 22, 2005
Making sense of DNA microarray dataWei-Min Liu, Sunhee K Ro, Walter H Koch
Journal of Clinical Psychopharmacology|September 15, 2005
Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illnessJose de Leon, Margaret T Susce, Run-Mei Pan, et al.
The Journal of Clinical Psychiatry|January 27, 2005
The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuationJose de Leon, Margaret T Susce, Run-Mei Pan, et al.
Anesthesiology|February 26, 2005
The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?Keith A Candiotti, David J Birnbach, David A Lubarsky, et al.
Clinical Chemistry|March 26, 2003
Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationshipsWen-Hwei Chou, Feng-Xiang Yan, Doris K Robbins-Weilert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based AnalysesTilak K Sundaresan, Lecia V Sequist, John V Heymach, et al.
Nature Methods|September 24, 2005
The External RNA Controls Consortium: a progress reportShawn C Baker, Steven R Bauer, Richard P Beyer, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Reviews. Drug Discovery|September 2, 2004
Technology platforms for pharmacogenomic diagnostic assaysWalter H Koch
New Biotechnology|March 7, 2012
Co-development of a companion diagnostic for targeted cancer therapySuzanne Cheng, Walter H Koch, Lin Wu
Biotechniques|October 21, 2005
Clinical applications of microarray-based diagnostic testsLin Wu, P Mickey Williams, Walter H Koch
Methods in Molecular Medicine|June 22, 2005
Making sense of DNA microarray dataWei-Min Liu, Sunhee K Ro, Walter H Koch
Journal of Clinical Psychopharmacology|September 15, 2005
Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illnessJose de Leon, Margaret T Susce, Run-Mei Pan, et al.
The Journal of Clinical Psychiatry|January 27, 2005
The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuationJose de Leon, Margaret T Susce, Run-Mei Pan, et al.
Anesthesiology|February 26, 2005
The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?Keith A Candiotti, David J Birnbach, David A Lubarsky, et al.
Clinical Chemistry|March 26, 2003
Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationshipsWen-Hwei Chou, Feng-Xiang Yan, Doris K Robbins-Weilert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based AnalysesTilak K Sundaresan, Lecia V Sequist, John V Heymach, et al.
Nature Methods|September 24, 2005
The External RNA Controls Consortium: a progress reportShawn C Baker, Steven R Bauer, Richard P Beyer, et al.
Pageof 1